Brief: Herantis Pharma: Update On Contemplated Directed Share Issue
March 12 (Reuters) - Herantis Pharma Oyj HRTIS.HE :
* UPDATE ON CONTEMPLATED DIRECTED SHARE ISSUE
* EXPECTS THAT DIRECTED ISSUE WOULD CONSIST OF ISSUING
TENTATIVELY
APPROXIMATELY 1,100,000 NEW SHARES AT A SUBSCRIPTION PRICE OF
EUR 5.20 PER SHARE
Source text for Eikon: ID:nGNEbjdPPf
Further company coverage: HRTIS.HE
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))